Cargando…

Soluble Programmed Cell Death Protein 1 and Its Ligand: Potential Biomarkers to Predict Acute Kidney Injury After Surgery in Critically Ill Patients

PURPOSE: Programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) have been detected in injury kidney. However, their expressions are unclear in mice kidneys under renal ischemia-reperfusion injury (IRI). In this study, we would observe the expressions of PD-1 and PD-L1 in kidney...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingyi, Zheng, Xi, Jiang, Yijia, Jia, Huimiao, Shi, Xiaocui, Han, Yue, Li, Qingping, Li, Wenxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959723/
https://www.ncbi.nlm.nih.gov/pubmed/35356070
http://dx.doi.org/10.2147/JIR.S356475
_version_ 1784677227059740672
author Wang, Jingyi
Zheng, Xi
Jiang, Yijia
Jia, Huimiao
Shi, Xiaocui
Han, Yue
Li, Qingping
Li, Wenxiong
author_facet Wang, Jingyi
Zheng, Xi
Jiang, Yijia
Jia, Huimiao
Shi, Xiaocui
Han, Yue
Li, Qingping
Li, Wenxiong
author_sort Wang, Jingyi
collection PubMed
description PURPOSE: Programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) have been detected in injury kidney. However, their expressions are unclear in mice kidneys under renal ischemia-reperfusion injury (IRI). In this study, we would observe the expressions of PD-1 and PD-L1 in kidney tissues and analyze the association between the concentrations of PD-1 and PD-L1 in mouse kidney homogenate and the corresponding concentrations of soluble PD-1 (sPD-1) and soluble PD-L1 (sPD-L1) in plasma after renal IRI. Further, we explored the predictive value of sPD-1 and sPD-L1 for acute kidney injury (AKI) in high-risk patients after surgery. METHODS: This study established an AKI model induced by IRI in mice. Plasma, kidney samples, and homogenate were collected 0h, 24h, and 48h after surgery for immunohistochemistry and enzyme-linked immunosorbent assay. Then, we continuously enrolled 88 AKI high-risk patients who underwent noncardiac surgery. The biomarkers, including sPD-1, sPD-L1, and urine neutrophil gelatinase-associated lipocalin (NGAL), tissue inhibitor of metalloproteinase-2 (TIMP-2), insulin-like growth factor-binding protein 7 (IGFBP7), were detected immediately after surgery. RESULTS: Our data revealed the concentrations of PD-1 and PD-L1 in kidney homogenate, and sPD-1 and sPD-L1 in plasma significantly increased at 0h, 24h, and 48h after IRI. A positive association was found between PD-1 and sPD-1 (r = 0.774, p < 0.001), and between PD-L1 and sPD-L1 (r = 0.881, p < 0.001). Compared to NGAL, [TIMP-2]*[IGFBP7], sPD-1 and sPD-L1 showed better predictive abilities for AKI with an area under the ROC curve of 0.856 (95% confidence interval [CI]: 0.825–0.958, p < 0.001) and 0.906 (95% CI: 0.764–0.921, p < 0.001). CONCLUSION: The increased expressions of PD-1 and PD-L1 in kidneys under IRI suggested they may play essential roles in AKI development. sPD-1 and sPD-L1 can indirectly reflect the expressions of PD-1 and PD-L1 in kidneys, respectively. sPD-1 and sPD-L1 showed excellent predictive ability for AKI in high-risk patients.
format Online
Article
Text
id pubmed-8959723
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-89597232022-03-29 Soluble Programmed Cell Death Protein 1 and Its Ligand: Potential Biomarkers to Predict Acute Kidney Injury After Surgery in Critically Ill Patients Wang, Jingyi Zheng, Xi Jiang, Yijia Jia, Huimiao Shi, Xiaocui Han, Yue Li, Qingping Li, Wenxiong J Inflamm Res Original Research PURPOSE: Programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) have been detected in injury kidney. However, their expressions are unclear in mice kidneys under renal ischemia-reperfusion injury (IRI). In this study, we would observe the expressions of PD-1 and PD-L1 in kidney tissues and analyze the association between the concentrations of PD-1 and PD-L1 in mouse kidney homogenate and the corresponding concentrations of soluble PD-1 (sPD-1) and soluble PD-L1 (sPD-L1) in plasma after renal IRI. Further, we explored the predictive value of sPD-1 and sPD-L1 for acute kidney injury (AKI) in high-risk patients after surgery. METHODS: This study established an AKI model induced by IRI in mice. Plasma, kidney samples, and homogenate were collected 0h, 24h, and 48h after surgery for immunohistochemistry and enzyme-linked immunosorbent assay. Then, we continuously enrolled 88 AKI high-risk patients who underwent noncardiac surgery. The biomarkers, including sPD-1, sPD-L1, and urine neutrophil gelatinase-associated lipocalin (NGAL), tissue inhibitor of metalloproteinase-2 (TIMP-2), insulin-like growth factor-binding protein 7 (IGFBP7), were detected immediately after surgery. RESULTS: Our data revealed the concentrations of PD-1 and PD-L1 in kidney homogenate, and sPD-1 and sPD-L1 in plasma significantly increased at 0h, 24h, and 48h after IRI. A positive association was found between PD-1 and sPD-1 (r = 0.774, p < 0.001), and between PD-L1 and sPD-L1 (r = 0.881, p < 0.001). Compared to NGAL, [TIMP-2]*[IGFBP7], sPD-1 and sPD-L1 showed better predictive abilities for AKI with an area under the ROC curve of 0.856 (95% confidence interval [CI]: 0.825–0.958, p < 0.001) and 0.906 (95% CI: 0.764–0.921, p < 0.001). CONCLUSION: The increased expressions of PD-1 and PD-L1 in kidneys under IRI suggested they may play essential roles in AKI development. sPD-1 and sPD-L1 can indirectly reflect the expressions of PD-1 and PD-L1 in kidneys, respectively. sPD-1 and sPD-L1 showed excellent predictive ability for AKI in high-risk patients. Dove 2022-03-24 /pmc/articles/PMC8959723/ /pubmed/35356070 http://dx.doi.org/10.2147/JIR.S356475 Text en © 2022 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Jingyi
Zheng, Xi
Jiang, Yijia
Jia, Huimiao
Shi, Xiaocui
Han, Yue
Li, Qingping
Li, Wenxiong
Soluble Programmed Cell Death Protein 1 and Its Ligand: Potential Biomarkers to Predict Acute Kidney Injury After Surgery in Critically Ill Patients
title Soluble Programmed Cell Death Protein 1 and Its Ligand: Potential Biomarkers to Predict Acute Kidney Injury After Surgery in Critically Ill Patients
title_full Soluble Programmed Cell Death Protein 1 and Its Ligand: Potential Biomarkers to Predict Acute Kidney Injury After Surgery in Critically Ill Patients
title_fullStr Soluble Programmed Cell Death Protein 1 and Its Ligand: Potential Biomarkers to Predict Acute Kidney Injury After Surgery in Critically Ill Patients
title_full_unstemmed Soluble Programmed Cell Death Protein 1 and Its Ligand: Potential Biomarkers to Predict Acute Kidney Injury After Surgery in Critically Ill Patients
title_short Soluble Programmed Cell Death Protein 1 and Its Ligand: Potential Biomarkers to Predict Acute Kidney Injury After Surgery in Critically Ill Patients
title_sort soluble programmed cell death protein 1 and its ligand: potential biomarkers to predict acute kidney injury after surgery in critically ill patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959723/
https://www.ncbi.nlm.nih.gov/pubmed/35356070
http://dx.doi.org/10.2147/JIR.S356475
work_keys_str_mv AT wangjingyi solubleprogrammedcelldeathprotein1anditsligandpotentialbiomarkerstopredictacutekidneyinjuryaftersurgeryincriticallyillpatients
AT zhengxi solubleprogrammedcelldeathprotein1anditsligandpotentialbiomarkerstopredictacutekidneyinjuryaftersurgeryincriticallyillpatients
AT jiangyijia solubleprogrammedcelldeathprotein1anditsligandpotentialbiomarkerstopredictacutekidneyinjuryaftersurgeryincriticallyillpatients
AT jiahuimiao solubleprogrammedcelldeathprotein1anditsligandpotentialbiomarkerstopredictacutekidneyinjuryaftersurgeryincriticallyillpatients
AT shixiaocui solubleprogrammedcelldeathprotein1anditsligandpotentialbiomarkerstopredictacutekidneyinjuryaftersurgeryincriticallyillpatients
AT hanyue solubleprogrammedcelldeathprotein1anditsligandpotentialbiomarkerstopredictacutekidneyinjuryaftersurgeryincriticallyillpatients
AT liqingping solubleprogrammedcelldeathprotein1anditsligandpotentialbiomarkerstopredictacutekidneyinjuryaftersurgeryincriticallyillpatients
AT liwenxiong solubleprogrammedcelldeathprotein1anditsligandpotentialbiomarkerstopredictacutekidneyinjuryaftersurgeryincriticallyillpatients